Technical Analysis for HILS - Hillstream BioPharma, Inc.

Grade Last Price % Change Price Change
B 3.13 21.79% 0.56
HILS closed up 21.79 percent on Thursday, January 20, 2022, on approximately normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A
Historical HILS trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 21.79%
Hot IPO Pullback Bullish Swing Setup 21.79%
New 52 Week Low Weakness 21.79%
Outside Day Range Expansion 21.79%
Hot IPO Pullback Bullish Swing Setup 12.59%
Inside Day Range Contraction 12.59%
Hot IPO Pullback Bullish Swing Setup 7.93%
New 52 Week Low Weakness 7.93%
Older End-of-Day Signals for HILS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% 3 days ago
Down 3% 3 days ago
Down 2 % 3 days ago
Down 1% 3 days ago
Possible Inside Day 3 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Hillstream BioPharma, Inc. Description

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a targeted bifunctional inhibitory compound in Quatramer with single digit nanomolar; IC50 against PI3K-delta and HDAC6, which is also known to downregulate; c-myc, a cancer drug target; and HSB-114, an immunotherapeutic agent, which uses its Quatramer technology to deliver tumor necrosis factor-alpha gene into cancer cells. The company was incorporated in 2019 and is based in Bridgewater, New Jersey.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Biology Solid Tumors Tumor Necrosis Anthracycline Treatment Resistant Cancers

Is HILS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.17
52 Week Low 2.52
Average Volume 1,089,914
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 0.00
Average True Range 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs) N/A
Chandelier Exit (Short, 3 ATRs) N/A
Upper Bollinger Bands 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.00
Resistance 3 (R3) 3.93 3.56 3.86
Resistance 2 (R2) 3.56 3.34 3.60 3.81
Resistance 1 (R1) 3.35 3.20 3.46 3.42 3.76
Pivot Point 2.98 2.98 3.04 3.02 2.98
Support 1 (S1) 2.77 2.76 2.88 2.84 2.50
Support 2 (S2) 2.40 2.62 2.44 2.45
Support 3 (S3) 2.19 2.40 2.41
Support 4 (S4) 2.26